Jean F. Voltaire

Array ( [id] => 5490864 [patent_doc_number] => 20090291935 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-11-26 [patent_title] => 'X-NITRO COMPOUNDS, PHARMACEUTICAL COMPOSITIONS THEREOF AND USES THEREOF' [patent_app_type] => utility [patent_app_number] => 12/429093 [patent_app_country] => US [patent_app_date] => 2009-04-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 8427 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0291/20090291935.pdf [firstpage_image] =>[orig_patent_app_number] => 12429093 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5480807 [patent_doc_number] => 20090203764 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-08-13 [patent_title] => 'INHIBITORS OF SEMICARBAZIDE-SENSITIVE AMINE OXIDASE (SSAO) AND VAP-1 MEDIATED ADHESION USEFUL FOR TREATMENT AND PREVENTION OF DISEASES' [patent_app_type] => utility [patent_app_number] => 12/426885 [patent_app_country] => US [patent_app_date] => 2009-04-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 16 [patent_figures_cnt] => 16 [patent_no_of_words] => 81513 [patent_no_of_claims] => 29 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0203/20090203764.pdf [firstpage_image] =>[orig_patent_app_number] => 12426885 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5551850 [patent_doc_number] => 20090285836 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-11-19 [patent_title] => 'USE OF SALINOSPORAMIDE A TO INHIBIT METASTASIS' [patent_app_type] => utility [patent_app_number] => 12/423713 [patent_app_country] => US [patent_app_date] => 2009-04-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 23 [patent_figures_cnt] => 23 [patent_no_of_words] => 17162 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0285/20090285836.pdf [firstpage_image] =>[orig_patent_app_number] => 12423713 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5954226 [patent_doc_number] => 20110034473 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-02-10 [patent_title] => 'NOVEL (PYRROLOQUINOXALINYL) PYRAZINECARBOHYDRAZIDE-OXALIC ACID CO-CRYSTAL FOR TREATMENT OF CANCER AND OTHER DISEASES' [patent_app_type] => utility [patent_app_number] => 12/937245 [patent_app_country] => US [patent_app_date] => 2009-04-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 26 [patent_figures_cnt] => 26 [patent_no_of_words] => 5771 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0034/20110034473.pdf [firstpage_image] =>[orig_patent_app_number] => 12937245 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9844246 [patent_doc_number] => 08946162 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2015-02-03 [patent_title] => 'Treatment of tumors' [patent_app_type] => utility [patent_app_number] => 12/937029 [patent_app_country] => US [patent_app_date] => 2009-04-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6132 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 109 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12937029 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5474313 [patent_doc_number] => 20090247479 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-10-01 [patent_title] => 'Therapeutic Use of Methionine to Reduce the Toxicity of Aminoglycoside Antibiotics' [patent_app_type] => utility [patent_app_number] => 12/418960 [patent_app_country] => US [patent_app_date] => 2009-04-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 14950 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0247/20090247479.pdf [firstpage_image] =>[orig_patent_app_number] => 12418960 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6482732 [patent_doc_number] => 20100008901 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-01-14 [patent_title] => 'METHODS FOR THE TREATMENT AND PREVENTION OF CANCER' [patent_app_type] => utility [patent_app_number] => 12/418380 [patent_app_country] => US [patent_app_date] => 2009-04-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 13515 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0008/20100008901.pdf [firstpage_image] =>[orig_patent_app_number] => 12418380 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6552834 [patent_doc_number] => 20100016783 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-01-21 [patent_title] => 'NON-INVASIVE SYSTEMS AND METHODS FOR IN-SITU PHOTOBIOMODULATION' [patent_app_type] => utility [patent_app_number] => 12/417779 [patent_app_country] => US [patent_app_date] => 2009-04-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 36 [patent_figures_cnt] => 36 [patent_no_of_words] => 48213 [patent_no_of_claims] => 297 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0016/20100016783.pdf [firstpage_image] =>[orig_patent_app_number] => 12417779 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5465777 [patent_doc_number] => 20090325977 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-12-31 [patent_title] => 'CANCER COMBINATION THERAPY COMPRISING AZD2171 AND IMATINIB' [patent_app_type] => utility [patent_app_number] => 12/408833 [patent_app_country] => US [patent_app_date] => 2009-03-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 7924 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0325/20090325977.pdf [firstpage_image] =>[orig_patent_app_number] => 12408833 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6589982 [patent_doc_number] => 20100062078 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-03-11 [patent_title] => 'PHARMACEUTICAL COMPOSITION FOR TREATING CANCER AND THE SIGNALING PATHWAY THEREOF' [patent_app_type] => utility [patent_app_number] => 12/399155 [patent_app_country] => US [patent_app_date] => 2009-03-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 23 [patent_figures_cnt] => 23 [patent_no_of_words] => 6843 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0062/20100062078.pdf [firstpage_image] =>[orig_patent_app_number] => 12399155 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5436275 [patent_doc_number] => 20090170862 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-07-02 [patent_title] => 'USE OF C-KIT INHIBITORS FOR THE TREATMENT OF MYELOMA' [patent_app_type] => utility [patent_app_number] => 12/393418 [patent_app_country] => US [patent_app_date] => 2009-02-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 6180 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0170/20090170862.pdf [firstpage_image] =>[orig_patent_app_number] => 12393418 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5392160 [patent_doc_number] => 20090209473 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-08-20 [patent_title] => 'Componds and methods for pormoting angiogenesis' [patent_app_type] => utility [patent_app_number] => 12/378731 [patent_app_country] => US [patent_app_date] => 2009-02-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 17 [patent_figures_cnt] => 17 [patent_no_of_words] => 9294 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0209/20090209473.pdf [firstpage_image] =>[orig_patent_app_number] => 12378731 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5527777 [patent_doc_number] => 20090197854 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-08-06 [patent_title] => 'USE OF PICOPLATIN TO TREAT COLORECTAL CANCER' [patent_app_type] => utility [patent_app_number] => 12/367394 [patent_app_country] => US [patent_app_date] => 2009-02-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6729 [patent_no_of_claims] => 27 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0197/20090197854.pdf [firstpage_image] =>[orig_patent_app_number] => 12367394 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10161451 [patent_doc_number] => 09192662 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2015-11-24 [patent_title] => 'Methods using immunomodulatory compounds for modulating level of CD59' [patent_app_type] => utility [patent_app_number] => 12/362411 [patent_app_country] => US [patent_app_date] => 2009-01-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 16115 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 69 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12362411 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5374879 [patent_doc_number] => 20090312440 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-12-17 [patent_title] => 'AGENT FOR IMPROVING TISSUE PENETRATION' [patent_app_type] => utility [patent_app_number] => 12/357003 [patent_app_country] => US [patent_app_date] => 2009-01-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 8880 [patent_no_of_claims] => 40 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0312/20090312440.pdf [firstpage_image] =>[orig_patent_app_number] => 12357003 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8921156 [patent_doc_number] => 08487093 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2013-07-16 [patent_title] => 'β-lactamase inhibitors' [patent_app_type] => utility [patent_app_number] => 12/812763 [patent_app_country] => US [patent_app_date] => 2009-01-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 41713 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12812763 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5586080 [patent_doc_number] => 20090105282 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-04-23 [patent_title] => 'METHODS OF TREATING BENIGN PROSTATIC HYPERPLASIA OR LOWER URINARY TRACT SYMPTOMS BY USING PDE 5 INHIBITORS' [patent_app_type] => utility [patent_app_number] => 12/337453 [patent_app_country] => US [patent_app_date] => 2008-12-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6002 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0105/20090105282.pdf [firstpage_image] =>[orig_patent_app_number] => 12337453 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5546795 [patent_doc_number] => 20090156672 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-06-18 [patent_title] => 'Substituted Phenyl Aziridine Precursor Analogs as Modulators of Steroid Receptor Activities' [patent_app_type] => utility [patent_app_number] => 12/335911 [patent_app_country] => US [patent_app_date] => 2008-12-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 11824 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0156/20090156672.pdf [firstpage_image] =>[orig_patent_app_number] => 12335911 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5441901 [patent_doc_number] => 20090093540 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-04-09 [patent_title] => 'ANTI-TUMOR COMPOSITION' [patent_app_type] => utility [patent_app_number] => 12/334846 [patent_app_country] => US [patent_app_date] => 2008-12-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6125 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0093/20090093540.pdf [firstpage_image] =>[orig_patent_app_number] => 12334846 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6070121 [patent_doc_number] => 20110044971 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-02-24 [patent_title] => 'METHOD AND COMPOSITION FOR TREATING A SERATONIN RECEPTOR-MEDIATED CONDITION' [patent_app_type] => utility [patent_app_number] => 12/747912 [patent_app_country] => US [patent_app_date] => 2008-12-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4655 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0044/20110044971.pdf [firstpage_image] =>[orig_patent_app_number] => 12747912 [rel_patent_id] =>[rel_patent_doc_number] =>)